(Q38612855)

4 September 2017

0 references

Translational failure of anti-inflammatory compounds for myocardial infarction: a meta-analysis of large animal models (English)

1 reference

4 September 2017

myocardial infarction

1 reference

1 reference

7

1 reference

4 September 2017

9

Gerard Pasterkamp

1 reference

4 September 2017

11

Imo E Hoefer

1 reference

4 September 2017

Emily S Sena

4

0 references

Wouter Van Solinge

object named as

Wouter W van Solinge

6

0 references

Pieter A Doevendans

8

object named as

Pieter A Doevendans

1 reference

4 September 2017

10

Steven A J Chamuleau

1 reference

4 September 2017

Gerardus P J van Hout

1

1 reference

4 September 2017

Sanne J Jansen of Lorkeers

2

1 reference

4 September 2017

Kimberly E Wever

3

1 reference

4 September 2017

Lisanne H J A Kouwenberg

5

1 reference

4 September 2017

20 October 2015

1 reference

4 September 2017

Cardiovascular Research

1 reference

4 September 2017

109

1 reference

4 September 2017

2

1 reference

4 September 2017

240-248

1 reference

Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010

4 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

The innate immune response in reperfused myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Innate immune signaling in cardiac ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Targeting inflammatory pathways in myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Healing and adverse remodelling after acute myocardial infarction: role of the cellular immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Genomic responses in mouse models poorly mimic human inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Ischemic postconditioning in pigs: no causal role for RISK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Myocardial reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Preclinical studies of human disease: time to take methodological quality seriously.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Publication bias in reports of animal stroke studies leads to major overstatement of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Can animal models of disease reliably inform human studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Meta-analysis of data from animal studies: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Cutting edge: IL-1α is a crucial danger signal triggering acute myocardial inflammation during myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

The inflammatory response in myocardial injury, repair, and remodelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

All preclinical trials should be registered in advance in an online registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Good laboratory practice: preventing introduction of bias at the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Learning: not just the facts, ma'am, but the counterfactuals as well

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Cardioprotection and myocardial reperfusion: pitfalls to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Overview of large animal myocardial infarction models (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Time trends in STEMI--improved treatment and outcome but still a gender gap: a prospective observational cohort study from the SWEDEHEART register

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

Estrogen and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVV239

21 January 2018

Identifiers

DOI

10.1093/CVR/CVV239

1 reference

4 September 2017

1 reference